Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

The Observational Medical Outcomes Partnership: Improving Post-Market Drug Safety

Research Project Aims To Improve Accuracy and Timeliness of Detecting Drug Risks and Benefits in Post-Market Environment

Bethesda, MD (December 6, 2010) - The Foundation for the National Institutes of Health (FNIH) announced the release of the publication "Advancing the Science for Active Surveillance: Rationale and Design for the Observational Medical Outcomes Partnership" in the Annals of Internal Medicine. Ann Intern Med November 2, 2010 153:600-606.

The Observational Medical Outcomes Partnership (OMOP) is a public-private partnership composed of representatives from the FDA, academia, 17 corporate and nonprofit organizations in the pharmaceutical industry and health care providers with large health claim or electronic health record databases. The partnership is focused on the need to advance the science of active medical product safety surveillance by using existing health databases.
Read more »

Read More: http://feedproxy.google.com/~r/mdjosephkim/~3/qxHOxG8Lqms/observational-medical-outcomes.html